Please Wait.....
Report
South Korea Cardiovascular Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-07-01 I 80 Pages I Mordor Intelligence
South Korea Cardiovascular Devices Market Analysis
The South Korea Cardiovascular Devices Market size is estimated at USD 1.29 billion in 2025, and is expected to reach USD 1.88 billion by 2030, at a CAGR of 7.96% during the forecast period (2025-2030).
The South Korea cardiovascular devices market size stands at USD 1.29 billion in 2025 and is forecast to reach USD 1.88 billion by 2030, advancing at a 7.96% CAGR during 2025-2030. Rising procedure volumes in an aging population, broadening National Health Insurance (NHI) reimbursement for transcatheter therapies, and rapid adoption of high-end imaging and AI software are accelerating demand. Therapeutic and surgical devices currently command 54.20% revenue share, but diagnostic and monitoring systems are expanding briskly on the back of remote-monitoring reimbursement and AI-enabled detection tools. Competitive intensity remains high, with multinationals focusing on premium technologies while domestic firms leverage cost advantages and government innovation grants to capture value-based sub-segments. Stringent Ministry of Food and Drug Safety (MFDS) pathways for Class-III heart valves, combined with a shortfall of provincial interventional cardiologists, temper market acceleration yet open avenues for telemedicine and training solutions.
South Korea Cardiovascular Devices Market Trends and Insights
Demographic Shift to a Super-Aged Society
South Korea already counts 17.5% of its citizens at least 65 years old in 2024, and official projections place seniors at nearly 35% by 2045. Cardiovascular procedure volumes are rising 12% each year, with octogenarians representing 22% of all percutaneous coronary interventions in 2024. Device makers have responded with geriatric-oriented designs that offer enhanced durability, simplified user interfaces, and embedded remote-monitoring chips. Hospitals are seeing longer lengths of stay and growing demand for low-profile catheters and smaller valve sizes that fit frail anatomies. These trends reinforce multiyear visibility for device replacement demand and recurring consumables.
NHI Reimbursement Expansion for Transcatheter Therapies
In April 2024 the National Health Insurance scheme extended coverage to transcatheter aortic valve replacement for intermediate-risk patients, opening treatment to an additional 4,200 cases annually. TAVR volumes jumped 37% quarter-over-quarter in Q2 2024, with Edwards Lifesciences and Medtronic jointly serving 78% of the expanded pool. The reimbursement upgrade also included drug-coated balloons for peripheral artery disease and next-generation left-atrial-appendage closure systems, giving suppliers multiple avenues for growth. Analysts at the Health Insurance Review & Assessment Service estimate a 22% increase in overall cardiovascular procedure volumes and an 8% reduction in total care costs tied to fewer surgical complications and shorter hospital stays.
Stringent MFDS Approval Pathway for Class-III Heart Valves
Enhanced MFDS regulations implemented in January 2024 require durability testing of 600 million cycles and thorough thrombogenicity profiling, extending approval timelines to 22 months compared with 11 months in the United States. Compliance expenses rose 35%, prompting three domestic valve developers to prioritize Southeast-Asian launches where requirements are lighter. Smaller firms face liquidity strain, while established players adjust by front-loading bench testing and investing in local clinical trials to shorten review cycles. Hospitals experience longer technology refresh lags, delaying patient access to latest-generation valves.
Other drivers and restraints analyzed in the detailed report include:
Rapid Uptake of High-End Imaging Modalities / Cardiovascular AI Software Adoption / Workforce Shortage of Interventional Cardiologists in Provincial Areas /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Therapeutic and surgical devices held a 54.20% revenue slice of the South Korea cardiovascular devices market in 2024, buoyed by high drug-eluting-stent penetration where DES comprised 87% of placements. The cardiac-rhythm-management niche is gaining renewed momentum after NHI endorsed leadless pacemakers and subcutaneous ICDs, sparking double-digit unit growth. Structural-heart interventions now absorb an expanding capital budget as TAVR case counts jumped 37% year-over-year following intermediate-risk coverage.
Diagnostic and monitoring devices, though smaller, are projected to show an 8.04% CAGR, outpacing the broader South Korea cardiovascular devices market. Remote cardiac monitors dominate momentum thanks to reimbursement for post-discharge surveillance paired with AI arrhythmia detection, a combination that cut heart-failure readmissions 42% in a 2024 multi-center trial. Echo systems sit atop diagnostic spending, with 3D strain imaging triggering accelerated replacement cycles, while optical fractional-flow-reserve systems gain share by slashing procedural time in cath labs.
The South Korea Cardiovascular Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices Including ECG Systems, Remote Cardiac Monitor, and More; Therapeutic & Surgical Devices Including Coronary Stents, Catheters, and More), Application (Coronary Artery Disease, Arrhythmia, and More), End User (Hospitals, Home Care Settings, Others). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Abbott Laboratories / Boston Scientific / Terumo Corp. / Edward Lifesciences / Koninklijke Philips / GEHealthcare / Siemens Healthineers / BIOTRONIK / Johnson & Johnson (Biosense Webster & Cordis Korea) / MicroPort Scientific Corp. / Osstem Cardiotech Co., Ltd / Genoss Co., Ltd / Nipro Corp. / Lepu Medical / Meril Life Sciences / Fukuda Denshi Co., Ltd / Nihon Kohden /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Demographic Shift to Super-Aged Society Boosting Cardio Procedure Volumes
4.2.2 NHI Reimbursement Expansion for Transcatheter Therapies
4.2.3 Rapid Uptake of High-End Imaging Modalities in Tertiary Hospitals
4.2.4 Cardiovascular AI Software Adoption Driven by Government "Digital Health" Grants
4.2.5 Domestic Innovation in Drug-Eluting Stent Coatings
4.2.6 Rise of Same-Day PCI Programs in Metropolitan Clinics
4.3 Market Restraints
4.3.1 Stringent MFDS Approval Pathway for Class-III Heart Valves
4.3.2 Workforce Shortage of Interventional Cardiologists in Provincial Areas
4.3.3 Declining Unit Prices Under KNHIS Price-Cut Cycles
4.3.4 High Reliance on Imported Heart-Valve Components Amid Weak Won
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces
4.7.1 Bargaining Power of Suppliers
4.7.2 Bargaining Power of Buyers
4.7.3 Threat of Substitutes
4.7.4 Threat of New Entrants
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value)
5.1 By Device
5.1.1 Diagnostic & Monitoring Devices
5.1.1.1 ECG Systems
5.1.1.2 Remote Cardiac Monitor
5.1.1.3 Cardiac MRI
5.1.1.4 Cardiac CT
5.1.1.5 Echocardiography / Ultrasound
5.1.1.6 Fractional Flow Reserve (FFR) Systems
5.1.2 Therapeutic & Surgical Devices
5.1.2.1 Coronary Stents
5.1.2.1.1 Drug-Eluting Stents
5.1.2.1.2 Bare-Metal Stents
5.1.2.1.3 Bioresorbable Stents
5.1.2.2 Catheters
5.1.2.2.1 PTCA Balloon Catheters
5.1.2.2.2 IVUS/OCT Catheters
5.1.2.3 Cardiac Rhythm Management
5.1.2.3.1 Pacemakers
5.1.2.3.2 Implantable Cardioverter Defibrillators
5.1.2.3.3 Cardiac Resynchronization Therapy Devices
5.1.2.4 Heart Valves
5.1.2.4.1 TAVR/TAVI
5.1.2.4.2 Mechanical Valves
5.1.2.4.3 Tissue/Bioprosthetic Valves
5.1.2.5 Ventricular Assist Devices
5.1.2.6 Artificial Hearts
5.1.2.7 Grafts & Patches
5.1.2.8 Other Cardiovascular Surgical Devices
5.2 By Indication
5.2.1 Coronary Artery Disease
5.2.2 Arrhythmia
5.2.3 Heart Failure
5.2.4 Valvular Heart Disease
5.3 By End User
5.3.1 Hospitals
5.3.2 Home care Settings
5.3.3 Others
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 Abbott Laboratories
6.3.2 Boston Scientific Corp.
6.3.3 Terumo Corp.
6.3.4 Edwards Lifesciences
6.3.5 Philips Healthcare
6.3.6 GE HealthCare
6.3.7 Siemens Healthineers
6.3.8 BIOTRONIK SE & Co. KG
6.3.9 Johnson & Johnson (Biosense Webster & Cordis Korea)
6.3.10 MicroPort Scientific Corp.
6.3.11 Osstem Cardiotech Co., Ltd
6.3.12 Genoss Co., Ltd
6.3.13 Nipro Corp.
6.3.14 Lepu Medical Technology
6.3.15 Meril Life Sciences
6.3.16 Fukuda Denshi Co., Ltd
6.3.17 Nihon Kohden Corporation
7 Market Opportunities & Future Outlook
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security